Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Event Logistics

- PMLiVE

CAR-Ts go head-to-head after NICE clears Kymriah in DLBCL

Novartis agrees pricing deal with NHS England

- PMLiVE

Vertex an “extreme outlier” in pricing and behaviour, says NHS England

Members of parliament aim to break three year deadlock

- PMLiVE

Ashfield partners with MIMS, WA Health wins new account and Lighthouse relocates

Latest healthcare comms news

- PMLiVE

Skills shortage and Brexit will hit R&D, warns UK pharma

Skill shortages and Brexit seen as greatest threat

- PMLiVE

GSK’s Advair Diskus faces first generic in US

Analysts predict around $250m in sales for Wixela Inhub this year

- PMLiVE

Ocrevus helps Roche shrug off biosimilars in 2018

Good news after Alzheimer's failure

- PMLiVE

Nerve centre gives Novartis edge in clinical trials

Algorithms predict potential delays

- PMLiVE

Novartis aims for 10 blockbuster launches by 2020

Includes new gene therapy Zolgensma

- PMLiVE

IQVIA sees market slowdown looming for pharma

Growth rates dip below the 6% average

- PMLiVE

Another amyloid bust as Roche pulls crenezumab trials

Undermines amyloid hypothesis hopes. including Biogen candidate

Lighthouse Medical Communications US goes large in the Big Apple

It’s a double celebration for Lighthouse Medical Communications US, a Lucid Group Company, as it celebrated its four-year anniversary, coupled with a move to impressive new offices in Financial District, Manhattan,...

Lucid Group Communications Limited

- PMLiVE

Horizon taps academic partner to boost gene editing platform

Partners with Rutgers University to license base editing tech

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links